SRI-37330

CAS No. 2322245-42-9

SRI-37330 ( —— )

Catalog No. M28482 CAS No. 2322245-42-9

SRI-37330 inhibits glucagon secretion and function, reduces hepatic glucose production, and reverses hepatic steatosis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 110 Get Quote
10MG 178 Get Quote
25MG 410 Get Quote
50MG 605 Get Quote
100MG 860 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    SRI-37330
  • Note
    Research use only, not for human use.
  • Brief Description
    SRI-37330 inhibits glucagon secretion and function, reduces hepatic glucose production, and reverses hepatic steatosis.
  • Description
    SRI-37330 inhibits glucagon secretion and function, reduces hepatic glucose production, and reverses hepatic steatosis.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    CK2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2322245-42-9
  • Formula Weight
    388.4
  • Molecular Formula
    C16H19F3N4O2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Protionamide

    Protionamide (or prothionamide) is a drug used in the treatment of tuberculosis.

  • Tigloylgomisin P

    Tigloylgomisin P shows moderate to marginal cytotoxicity against A549, PC-3, KB and KBvin human cancer cell lines.

  • Plantamajoside

    Plantamajoside has anti-hepatotoxic, anti-inflammatory, antinociceptive activities, improving sexual function and antioxidant activity.